Abstract
In 17 children on carbamazepine medication alone and 15 children on combined drug regimens, carbamazepine levels were determined in paired samples of serum and mixed saliva by enzyme immunoassay. Carbamazepine levels in serum and saliva were highly correlated in within-patient and between-patient series (r=0.87–0.94). Salivary levels were altered to a minor and clinically insignificant degree by stimulation of saliva flow. Mean saliva/serum ratios, calculated from drug concentrations in saliva specimens collected without and with stimulation were 0.44–0.45 and 0.41–0.43, respectively. The saliva/serum ratio was independent of the serum carbamazepine level and was not affected by concomitant drug medication. The data indicate that measuring salivary levels by enzyme immunoassay is suitable for predicting serum carbamazepine levels. Thus, measurement of carbamazepine levels in mixed saliva samples obtained by a noninvasive technique is recommended for routine monitoring of carbamazepine medication in epileptic children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cook, C. E., Amerson, E., Poole, W. K., Lesser, P., O'Tuama, L.: Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin. Pharmacol. Ther. 18, 742–747 (1975)
Di Salle, E., Pacifici, G. M., Morselli, P. L.: Studies in plasma protein binding of carbamazepine. Pharmacol. Res. Commun. 6, 193–202 (1974)
Dvorchik, B. H., Vesell, E. S.: Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clin. Chem. 22, 868–878 (1976)
Hooper, W. D., Dubetz, D. K., Bochner, F., Cotter, L. M., Smith, G. A., Eadie, M. J., Tyrer, J. H.: Plasma protein binding of carbamazepine. Clin. Pharmacol. Ther. 17, 433–440 (1975)
Horning, M. G., Brown, L., Nowlin, J., Lertratanangkoon, K., Kellaway, P., Zion, T. E.: Use of saliva in therapeutic drug monitoring. Clin. Chem. 23, 157–164 (1977)
Johannessen, S. I., Standjord, R. E.: The concentration of carbamazepine (Tegretol®) in serum and cerebrospinal fluid in patients with epilepsy. Acta Neurol. Scand. 48, Suppl. 51, 445–446 (1972)
Morselli, P. L., Gerna, M., De Maio, D., Zanda, G., Viani, F., Garattini, S.: Pharmacokinetic studies on carbamazepine in volunteers and in epileptic patients. In: Clinical pharmacology of anti-epileptic drugs (eds. H. Schneider, D. Janz, C. Gardner-Thorpe, H. Meinardi, A. L. Sherwin), pp. 166–180. Berlin-Heidelberg-New York: Springer 1975
Paxton, J. W., Whiting, B., Rowell, F. J., Ratcliffe, J. G., Stephen, K. W.: Salivary concentrations of antiepileptic drugs. Lancet 1976 II, 639–640
Rane, A., Höjer, B., Wilson, J. T.: Kinetics of carbamazepine and its 10, 11-epoxide metabolite in children. Clin. Pharmacol. Ther. 19, 276–283 (1976)
Rawlins, M. D., Collste, P., Bertilsson, L., Palmér, L.: Distribution and elimination kinetics of carbamazepine in man. Eur. J. Clin. Pharmacol. 8, 91–96 (1975)
Reynolds, F., Jones, N. F., Ziroyanis, P. N., Smith, S. E.: Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet 1976 II, 384–386
Schmidt, D.: Salivary concentrations of antiepileptic drugs. Lancet 1976 II, 639
Schmidt, D., Kupferberg, H. J.: Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia 16, 735–741 (1975)
Schmidt, D., Kupferberg, H. J.: Antiepileptic drugs in saliva: Clinical applications. In: Epileptology (ed. D. Janz), pp. 419–425. Stuttgart: Thieme 1976
Troupin, A. S., Friel, P.: Anticonvulsant level in saliva, serum and cerebrospinal fluid. Epilepsia 16, 223–227 (1975)
Author information
Authors and Affiliations
Additional information
Supported by Deutsche Forschungsgemeinschaft (Ba 246/11)
The data comprise part of the doctoral thesis of Elke Günther, University of Kiel
Rights and permissions
About this article
Cite this article
Bartels, H., Oldigs, H.D. & Günther, E. Use of saliva in monitoring carbamazepine medication in epileptic children. Eur J Pediatr 126, 37–44 (1977). https://doi.org/10.1007/BF00443121
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00443121